drug

Cyber fraudsters behind sale of drugs, crime against women and children: DGP

60,000 students participate virtually from 900 schools in Tirupati district




drug

Escient launches to tackle itching and anaphylactoid drug targets

The startup raised $40 million to target a class of GPCRs called Mas-related G-protein receptors, to treat neuroimmune and inflammatory conditions




drug

Smashing drugs illuminates troublesome microcrystals

Unwanted crystals could adversely affect drug stability and shelf life




drug

Can single-cell genomics lead to a new wave of drug targets? Celsius Therapeutics thinks so

The start-up, based on the work of Broad Institute scientist Aviv Regev, has raised $65 million to develop therapies for cancer and autoimmune disease




drug

Celsius Therapeutics launches to tap single-cell genomics for drug discovery




drug

Celgene to pay Evotec $65 million in cancer drug pact




drug

Drug service provider Alcami to go to another private equity firm

New investor takes on a company trying to combine a range of pharmaceutical services




drug

At BIO convention, business boomed, and drug pricing loomed

Diversity, drug prices, and 'right to try' permeated conversation at the drug industry meeting




drug

Roche ends development of SMA drug olesoxime




drug

Drug service provider Alcami to go to another private equity firm

New investor takes on a company trying to combine a range of pharmaceutical services




drug

A quest to drug the undruggable

Listen to the latest Stereo Chemistry episode that explores why certain drug targets are so vexing, and the cutting edge approaches chemists are taking to finally crack them




drug

Out of the sea and into the factory for Acasti’s heart drug ingredient

Acasti picks CordenPharma to extract omega-3s from krill




drug

Theracos becomes increasingly reliant on contract manufacturing as its drug advances

Piramal sites on different continents have become involved in producing Theracos’s diabetes treatment




drug

Celgene partners with Skyhawk Therapeutics to drug RNA with small molecules

Skyhawk will receive $60 million up front to develop drug candidates that target RNA in neurological diseases




drug

Ferreting out why some cancer drugs struggle to shrink tumors

Study shows how stopping one enzyme could help drugs treat an important class of cancers more effectively




drug

Dynacure launches with $55 million and Ionis antisense oligonucleotide drug

The French startup will develop an RNA-targeted therapy for the rare muscle disease centronuclear myopathy




drug

Catalent acquires drug services firm Juniper




drug

Trump’s tweets prompt Pfizer to postpone drug price hikes

The president deemed the price rollback a victory, but industry watchers say Pfizer could benefit in the long run




drug

Verge Genomics raises $32 million for machine learning-backed neuroscience drug discovery




drug

Cambrex to acquire dosage-form drug contractor Halo

With purchase, manufacturer of active pharmaceutical ingredients will move downstream into finished drugs




drug

GSK, 23andMe to apply personal genetics to drug discovery

New partnership is part of GSK’s R&D face-lift, which includes an increased focus on immune system targets




drug

New mechanism proposed for old diabetes drug

Type 2 diabetes drug metformin impedes glucose overproduction in a redox-dependent manner, researchers say




drug

Cambrex to acquire dosage-form drug contractor Halo

With purchase, manufacturer of active pharmaceutical ingredients will move downstream into finished drugs




drug

FDA considers imports to tackle high U.S. drug prices




drug

Meet the exosome, the rising star in drug delivery

Companies are hoping to use the vesicles to package small-molecule, protein, and RNA drugs or even use them as therapies themselves




drug

The value of priority review vouchers for drugmakers is falling




drug

Aarti Drugs Ltd. - Shareholder Meeting / Postal Ballot-Outcome of AGM




drug

Drugged days




drug

Pune police bust gang smuggling marijuana from Odisha on train, seize drugs worth Rs 12 lakh




drug

2020 Mephedrone bust: Trial begins against 19 accused, drug cartel kingpin Lalit Patil




drug

Tweaks in drug formulations to extend copyrights is a public health challenge




drug

Dr Reddy’s recalls 1,752 bottles of heartburn drug in the US

Drug major Dr Reddy’s Laboratories is recalling 1,752 bottles of generic heartburn medicine in the US after the American health regulator found qual




drug

Dr Reddy’s recalls few bottles of heartburn drug from US

Pharma major Dr Reddy’s Laboratories Ltd has initiated recall of 1m752 bottles of generic Esomeprazole Magnesium delayed release capsules in the US.A





drug

The federal government finally announced initial plans to distribute Gilead's coronavirus drug remdesivir after days of confusion

The government said it's distributing the promising coronavirus drug, remdesivir, to some hard-hit states. Eventually, all 50 states should get it.





drug

Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias [Cell Biology]

Multidrug resistance (MDR) in cancer arises from cross-resistance to structurally- and functionally-divergent chemotherapeutic drugs. In particular, MDR is characterized by increased expression and activity of ATP-binding cassette (ABC) superfamily transporters. Sphingolipids are substrates of ABC proteins in cell signaling, membrane biosynthesis, and inflammation, for example, and their products can favor cancer progression. Glucosylceramide (GlcCer) is a ubiquitous glycosphingolipid (GSL) generated by glucosylceramide synthase, a key regulatory enzyme encoded by the UDP-glucose ceramide glucosyltransferase (UGCG) gene. Stressed cells increase de novo biosynthesis of ceramides, which return to sub-toxic levels after UGCG mediates incorporation into GlcCer. Given that cancer cells seem to mobilize UGCG and have increased GSL content for ceramide clearance, which ultimately contributes to chemotherapy failure, here we investigated how inhibition of GSL biosynthesis affects the MDR phenotype of chronic myeloid leukemias. We found that MDR is associated with higher UGCG expression and with a complex GSL profile. UGCG inhibition with the ceramide analog d-threo-1-(3,4,-ethylenedioxy)phenyl-2-palmitoylamino-3-pyrrolidino-1-propanol (EtDO-P4) greatly reduced GSL and monosialotetrahexosylganglioside levels, and co-treatment with standard chemotherapeutics sensitized cells to mitochondrial membrane potential loss and apoptosis. ABC subfamily B member 1 (ABCB1) expression was reduced, and ABCC-mediated efflux activity was modulated by competition with nonglycosylated ceramides. Consistently, inhibition of ABCC-mediated transport reduced the efflux of exogenous C6-ceramide. Overall, UGCG inhibition impaired the malignant glycophenotype of MDR leukemias, which typically overcomes drug resistance through distinct mechanisms. This work sheds light on the involvement of GSL in chemotherapy failure, and its findings suggest that targeted GSL modulation could help manage MDR leukemias.




drug

Rising drug prices drive US manufacturers’ revenues, analysis finds




drug

US drug costs are rising faster than overall health spending, officials report




drug

US drug makers have imposed big price rises for top selling drugs, study finds




drug

Cancer Drugs Fund requires further reform




drug

Perspective: Existing drugs could be repurposed for COVID-19 patients

Given the rapid spread of COVID-19 and its relatively high mortality, filling the gap for coronavirus-specific drugs is urgent.




drug

Former drug addict works with homeless in Athens

After working with the needy on a Transform 2012 outreach to Greece, Anthony (UK) returned to Athens to continue in that ministry.




drug

Hunting for an anti-COVID-19 drug

WHO’s Solidarity and Oxford’s RECOVERY trials can give a clearer picture on some drugs that showed early promise.




drug

Coronavirus COVID 19 vaccine: France-based drugmaker Sanofi to start large scale human trials

Coronavirus COVID 19 vaccine news, latest update, human trials: Sanofi's Pasteur division has an established track record in influenza vaccines. Last month it had teamed with its British rival GSK to produce a vaccine candidate hoping that it will be ready in 2021.








drug

Mohmand elders demand action against drug mafia

GHALLANAI: Local elders have demanded the government to take action against drug mafia in Mohmand tribal district.Speaking to journalists, social workers and elders including Malik Jehanzeb, Malik Salim, Malik Rasool Khan and others said that on the one hand coronavirus has created a risk to lives...




drug

PICS: Man arrested with drugs worth almost R4m hidden in his spare tyre

CALVINIA - A 56-year-old Johannesburg man was arrested by South African Police Service (SAPS) officers during a roadblock at Calvinia this past week after drugs with an estimated street value of almost R4 million...